Ventyx Biosciences (VTYX) Earnings Date & Reports

Ventyx Biosciences Inc is a clinical-stage biopharmaceutical company focused on advancing new therapies for millions of patients living with inflammatory diseases and autoimmune, and neurodegenerative disorders... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

VTYX is expected to report earnings to rise 19.17% to -48 cents per share on May 08

Ventyx Biosciences VTYX Stock Earnings Reports

Q1'25

Est.

$-0.49

Q4'24

Beat

by $0.13

Q3'24

Beat

by $0.02

Q2'24

Beat

by $0.13

Q1'24

Beat

by $0.06

The last earnings report on February 27 showed earnings per share of -40 cents, beating the estimate of -54 cents. With 809.94K shares outstanding, the current market capitalization sits at 75.40M.

View a ticker or compare two or three

Compare

VTYX